Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2024-05-20
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Experience of Adolescents With Anorexia Nervosa Towards Antidepressants
NCT04481165
Assessment of the Impact of Early Treatment for Anorexia Nervosa in a Day Hospital on Food Symptomatology, the Outcome of Young Patients, and the Family Experience
NCT06218472
Qualitative Evaluation of Change Processes in Multifamily Therapy for Adolescents With Anorexia Nervosa
NCT06091306
Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa
NCT06097247
Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID)
NCT04387708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Reactions to the proposal of antidepressant with an opposition phase (about the existence of depressive symptoms and about negative preconceptions) and need to share with family and other teenagers.
2. Reactions to antidepressant use with ambivalence and an initial perception of coercion, and effects of antidepressants (psychological effects, effects on the body and on anorexia nervosa and effects perceived through the eyes of others).
Nine adolescents (out of 15) were also taking an atypical antipsychotic (APA) often prescribed in case of anorexia nervosa resistance.
The need to share with family about the proposal of antidepressant and the effects perceived through the eyes of others (including parent's eyes) lead us to take an interest in parents perceptions.
Two decisive periods were identified: What do healthcare professionals think about psychotropic treatments for anorexia nervosa in adolescence? How do they propose treatment?
Interviewing teenagers, their parents as well as healthcare professionals, will enable to access to the complexity of representations and experiences of these psychotropic drugs in anorexia nervosa.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescents
Adolescents suffering from anorexia nervosa 12 to 25 years
Semi-structured interviews with visual mediations
Semi-structured interviews with visual mediations / An hour-long interview
Parents
Parents whose adolescents suffer from anorexia nervosa
Semi-structured interviews with visual mediations
Semi-structured interviews with visual mediations / An hour-long interview
Healthcare professionals
Healthcare professionals in charge of adolescents suffering from anorexia nervosa
Semi-structured interviews
Semi-structured interviews
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Semi-structured interviews with visual mediations
Semi-structured interviews with visual mediations / An hour-long interview
Semi-structured interviews
Semi-structured interviews
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 12 to 25 years
* Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
* Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started
Healthcare Professionals working with adolescents suffering from eating disorders
Exclusion Criteria
* Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
* BMI\<15
* Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
* Prescription of an APA for the indication of psychotic symptoms
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corinne Blanchet, MD
Role: STUDY_DIRECTOR
Cochin Hospital (maison de Solenn)
Marie Rose Moro, MD, PhD
Role: STUDY_DIRECTOR
Cochin Hospital (maison de Solenn)
Maude Ludot-Gregoire, MD
Role: PRINCIPAL_INVESTIGATOR
Cochin Hospital (maison de Solenn)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maison de Solenn Maison des Adolescents, Cochin Hospital
Paris, IDF, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ludot-Gregoire M, David V, Carretier E, Lachal J, Moro MR, Blanchet C. Subjective Experience of Antidepressant Prescription Among Adolescents With Anorexia Nervosa. Front Psychiatry. 2022 Apr 4;13:770903. doi: 10.3389/fpsyt.2022.770903. eCollection 2022.
Related Links
Access external resources that provide additional context or updates about the study.
First qualitative study (E3A Protocol)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A02141-42
Identifier Type: OTHER
Identifier Source: secondary_id
APHP230062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.